What is Edgewise Therapeutics, Inc. Common Stock's Market Cap?

Edgewise Therapeutics, Inc. Common Stock's Market Cap is $4.7B, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's Enterprise Value?

Edgewise Therapeutics, Inc. Common Stock's Enterprise Value is $4.7B, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's EV / EBITDA?

Edgewise Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's Net Income (TTM)?

Edgewise Therapeutics, Inc. Common Stock's Net Income (TTM) is -$197.2M, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's EBITDA?

Edgewise Therapeutics, Inc. Common Stock's EBITDA is -$216.8M, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Edgewise Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.82, based on as-reported figures from SEC (XBRL) filings.

What is Edgewise Therapeutics, Inc. Common Stock's Net Debt?

Edgewise Therapeutics, Inc. Common Stock's Net Debt is -$72.3M, based on as-reported figures from SEC (XBRL) filings.

Edgewise Therapeutics, Inc. Common Stock (EWTX) Financial Statements

Edgewise Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00K4Y2H33

XNAS · usd

43.51▼ 0.31 (-0.71%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close43.82

Day's Range42.21 – 44.92

52-Week Range13.69 – 48.40

Volume1.3M

Avg Volume1.1M

Share Statistics

Shares Outstanding

Employees146

ExchangeXNAS

Listed2021-03-26

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Edgewise Therapeutics, Inc. Common Stock (EWTX)

What is Edgewise Therapeutics, Inc. Common Stock's Market Cap?: Edgewise Therapeutics, Inc. Common Stock's Market Cap is $4.7B, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's Enterprise Value?: Edgewise Therapeutics, Inc. Common Stock's Enterprise Value is $4.7B, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's EV / EBITDA?: Edgewise Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's Net Income (TTM)?: Edgewise Therapeutics, Inc. Common Stock's Net Income (TTM) is -$197.2M, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's EBITDA?: Edgewise Therapeutics, Inc. Common Stock's EBITDA is -$216.8M, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Edgewise Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.82, based on as-reported figures from SEC (XBRL) filings.
What is Edgewise Therapeutics, Inc. Common Stock's Net Debt?: Edgewise Therapeutics, Inc. Common Stock's Net Debt is -$72.3M, based on as-reported figures from SEC (XBRL) filings.